Approval · Notice of Compliance 5037 · 1995
GLICLAZIDE: Notice of Compliance 5037
Issued March 6, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5037
- Date
- March 6, 1995
- Company
- Proval Pharma Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Hypoglycemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLICLAZIDE | 02155850 | Cancelled Post Market |
Medicinal ingredients
- GLICLAZIDE 80 MG per TAB